Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SQUARES: Sulodexide in Post-thrombotic Syndrome
NCT02512601Phase 4Terminated
- Sponsor
- Bama-Geve, S.L.U.
- Start
- Sep 2015
- Primary completion
- Feb 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sulodexide in post-thrombotic syndrome (PTS), sponsored by Bama-Geve, S.L.U.. Started Sep 2015; status: terminated.
02
Drugs
sulodexide
03
Conditions
post-thrombotic syndrome (PTS)
Beyond the preview
Go deeper on NCT02512601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02512601.